Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of Raltegravir (MK-0518) in Healthy Japanese Male Participants (MK-0518-851) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing safety, tolerability, and pharmacokinetics of HIV integrase inhibitor raltegravir in healthy Japanese male participants; comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Raltegravir (raltegravir)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Human Immunodeficiency Virus (HIV) Infection | Phase 4 | Status: COMPLETED | Results posted: 2019-10-02